
Ningdan Pharma
宁丹新药
Ningdan Pharma
Biotech/Healthcare
Ningdan New Drug was founded in 2020 and is headquartered in Nanjing, China. The company focuses on developing novel drugs for central nervous system disorders and is committed to finding practical treatment solutions for patients with these conditions.
Latest round: Series C (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.